PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer (Q47938015)

6 February 2018

title

PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer (English)

1 reference

6 February 2018

1 reference

Emmanuella Guenova

0 references

Thomas Schweiger

Thomas Schweiger

0 references

Sebastian F Schoppmann

Sebastian F Schoppmann

0 references

Konrad Hoetzenecker

1 reference

6 February 2018

Walter Klepetko

Walter Klepetko

1 reference

6 February 2018

Wolfram Hoetzenecker

Wolfram Hoetzenecker

1 reference

6 February 2018

Gerrit Lewik

Gerrit Lewik

1 reference

6 February 2018

Dagmar Kollmann

Dagmar Kollmann

1 reference

6 February 2018

author name string

Stefan Schwarz

1 reference

6 February 2018

Desislava Ignatova

1 reference

6 February 2018

Yun-Tsan Chang

1 reference

6 February 2018

publication date

18 August 2017

1 reference

6 February 2018

published in

OncoImmunology

1 reference

6 February 2018

volume

1 reference

6 February 2018

issue

1 reference

6 February 2018

page(s)

e1331194

1 reference

6 February 2018

Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis

cites work

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Reported outcome factors for pulmonary resection in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Long-term outcomes after surgical resection of pulmonary metastases from colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Adjusting for multiple testing--when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Programmed death-ligand 1 expression in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Advantages and limitations of microarray technology in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2017.1331194

Programmed death 1 immune checkpoint inhibitors

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599080

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28932634

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/2162402X.2017.1331194

1 reference

6 February 2018

PMC publication ID

5599080

0 references

1 reference

6 February 2018